- Home
- PEBO vs FBIOP Comparison
PEBO vs FBIOP Comparison
Compare PEBO & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBO
- FBIOP
- Stock Information
- Founded
- PEBO 1902
- FBIOP N/A
- Country
- PEBO United States
- FBIOP United States
- Employees
- PEBO N/A
- FBIOP 186
- Industry
- PEBO Major Banks
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- PEBO Finance
- FBIOP Health Care
- Exchange
- PEBO Nasdaq
- FBIOP Nasdaq
- Market Cap
- PEBO N/A
- FBIOP N/A
- IPO Year
- PEBO N/A
- FBIOP N/A
- Fundamental
- Price
- PEBO $31.30
- FBIOP $6.98
- Analyst Decision
- PEBO Hold
- FBIOP
- Analyst Count
- PEBO 3
- FBIOP 0
- Target Price
- PEBO $35.33
- FBIOP N/A
- AVG Volume (30 Days)
- PEBO 126.4K
- FBIOP N/A
- Earning Date
- PEBO 01-21-2025
- FBIOP N/A
- Dividend Yield
- PEBO 5.11%
- FBIOP N/A
- EPS Growth
- PEBO 3.01
- FBIOP N/A
- EPS
- PEBO 3.51
- FBIOP N/A
- Revenue
- PEBO $428,740,000.00
- FBIOP N/A
- Revenue This Year
- PEBO N/A
- FBIOP N/A
- Revenue Next Year
- PEBO $1.00
- FBIOP N/A
- P/E Ratio
- PEBO $8.92
- FBIOP N/A
- Revenue Growth
- PEBO 10.64
- FBIOP N/A
- 52 Week Low
- PEBO $26.74
- FBIOP N/A
- 52 Week High
- PEBO $37.07
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- PEBO 41.83
- FBIOP 56.58
- Support Level
- PEBO $30.93
- FBIOP $6.75
- Resistance Level
- PEBO $32.40
- FBIOP $6.97
- Average True Range (ATR)
- PEBO 0.84
- FBIOP 0.38
- MACD
- PEBO 0.05
- FBIOP -0.02
- Stochastic Oscillator
- PEBO 55.76
- FBIOP 70.37
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.